Massicotte, Marie-Hélène <br/><br/>
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.  [electronic resource] 

 -  European journal of endocrinology  Apr 2014 
 - 575-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1479-683X 
<br/><br/><label>Standard No.: </label>10.1530/EJE-13-0825  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Follicular--drug therapy<br/>Adenoma, Oxyphilic<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Carcinoma, Neuroendocrine<br/>Carcinoma, Papillary<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Indoles--therapeutic use<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Piperidines--therapeutic use<br/>Pleural Neoplasms--drug therapy<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--therapeutic use<br/>Quinazolines--therapeutic use<br/>Retrospective Studies<br/>Sorafenib<br/>Sunitinib<br/>Thyroid Cancer, Papillary<br/>Thyroid Neoplasms--drug therapy<br/>Treatment Outcome